Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWUXL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,089
Award facts
- Contract value 100% obligated
- $24,088.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, with a ceiling value of $24,088.76. The award covers the supply of Jakafi 10 mg tablets in quantities of 60 units, with an ultimate completion date of September 29, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a consistent portfolio of contracts delivering specialized medications and medical products to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FWUXL?
SPE2DB25FWUXL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWUXL worth?
The government has obligated $24,089 on SPE2DB25FWUXL.
Is contract SPE2DB25FWUXL an order under another contract?
Yes. SPE2DB25FWUXL is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUXL competed?
The extent of competition for SPE2DB25FWUXL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award